Difference between papillary and follicular thyroid carcinoma outcomes: an experience from Egyptian institution.
about
Demonstration of a potent RET transcriptional inhibitor for the treatment of medullary thyroid carcinoma based on an ellipticine derivative.Comparison of prognostic scoring systems in follicular thyroid cancer.BRAFV600E mutation is not associated with central lymph node metastasis in all patients with papillary thyroid cancer: Different histological subtypes and preoperative lymph node status should be taken into account.Genetic variations in TAS2R3 and TAS2R4 bitterness receptors modify papillary carcinoma risk and thyroid function in Korean femalesRoutine thyroglobulin, neck ultrasound and physical examination in the routine follow up of patients with differentiated thyroid cancer-Where is the evidence?
P2860
Difference between papillary and follicular thyroid carcinoma outcomes: an experience from Egyptian institution.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Difference between papillary a ...... nce from Egyptian institution.
@ast
Difference between papillary a ...... nce from Egyptian institution.
@en
type
label
Difference between papillary a ...... nce from Egyptian institution.
@ast
Difference between papillary a ...... nce from Egyptian institution.
@en
prefLabel
Difference between papillary a ...... nce from Egyptian institution.
@ast
Difference between papillary a ...... nce from Egyptian institution.
@en
P2860
P1476
Difference between papillary a ...... nce from Egyptian institution.
@en
P2093
Engy M Aboelnaga
Rehab Allah Ahmed
P2860
P356
10.7497/J.ISSN.2095-3941.2015.0005
P577
2015-03-01T00:00:00Z